YOKNEAM, Israel, Nov. 11, 2013 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that Dr. Shimon Eckhouse, Chief Executive Officer, and Hugo Goldman, Chief Financial Officer, are scheduled to participate in three upcoming investor conferences.
The first conference is the Canaccord Genuity Medical Technologies & Diagnostics Forum in New York City. Dr. Eckhouse will participate on behalf of the Company.
Conference: Canaccord Genuity Medical Technologies & Diagnostics Forum Date: Thursday, November 14, 2013 Time: 1:00 pm ET
The second conference is the Barclays Select Growth Conference in New York City. Dr. Eckhouse will participate on behalf of the Company.
Conference: Barclays Select Growth Conference Date: Monday, November 18, 2013 Time: 11:30 am ET
The third conference is the Jefferies 2013 Global Healthcare Conference in London. Mr. Goldman will participate on behalf of the Company.
Conference: Jefferies 2013 Global Healthcare Conference Date: Wednesday, November 20, 2013 Time: 8:00 am GMT (3:00 am ET)
The presentations will be webcast live over the Internet and can be accessed through the Investor Relations section on Syneron's website at www.investors.syneron.com. Please go to the website a few minutes early, as it may be necessary to download audio software to hear the presentations.
About Syneron Medical Ltd. Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The Company markets and services and supports its products in 90 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.
SOURCE Syneron Medical Ltd.